Sort   by:  
 Page size 
UnknownEvaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.
Not available
S-EPMC4971744 | biostudies-literature
UnknownPembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report.
Not available
S-EPMC11907546 | biostudies-literature
UnknownThe side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics.
Not available
S-EPMC4196181 | biostudies-literature
UnknownIntegrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy.
Not available
S-EPMC11634877 | biostudies-literature
UnknownTumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcome.
Not available
S-EPMC11671916 | biostudies-literature
UnknownHigh RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome.
Not available
S-EPMC7028124 | biostudies-literature
UnknownBRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer.
Not available
S-EPMC6173779 | biostudies-literature
UnknownBRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer.
Not available
S-EPMC5915132 | biostudies-literature
UnknownDNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer.
Not available
S-EPMC3062717 | biostudies-literature
UnknownThe miR-34 family and its clinical significance in ovarian cancer.
Not available
S-EPMC6995379 | biostudies-literature
Sort   by:  
 Page size